Page last updated: 2024-11-04

linsidomine and Breast Neoplasms

linsidomine has been researched along with Breast Neoplasms in 1 studies

linsidomine: RN given refers to parent cpd; structure

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
" Given that the activity of NAT1 depends on a reactive cysteine that can be a target for oxidants, we studied whether peroxynitrite, a highly reactive nitrogen species involved in human carcinogenesis, could inhibit the activity of endogenous NAT1 in MCF7 breast cancer cells."3.72Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: a cellular and mechanistic study. ( Atmane, N; Dairou, J; Dupret, JM; Rodrigues-Lima, F, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dairou, J1
Atmane, N1
Rodrigues-Lima, F1
Dupret, JM1

Other Studies

1 other study available for linsidomine and Breast Neoplasms

ArticleYear
Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: a cellular and mechanistic study.
    The Journal of biological chemistry, 2004, Feb-27, Volume: 279, Issue:9

    Topics: Arylamine N-Acetyltransferase; Breast Neoplasms; Cysteine; Dithiothreitol; Enzyme Inhibitors; Glutat

2004